- Home
- FDBC vs ARCT Comparison
FDBC vs ARCT Comparison
Compare FDBC & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FDBC | ARCT |
|---|---|---|
| Founded | 1902 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 262.3M | 245.4M |
| IPO Year | 2000 | 2019 |
Fundamental Metrics
Financial Performance| Metric | FDBC | ARCT |
|---|---|---|
| Price | $45.45 | $6.87 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 10 |
| Target Price | N/A | ★ $24.11 |
| AVG Volume (30 Days) | 4.3K | ★ 382.5K |
| Earning Date | 04-22-2026 | 05-07-2026 |
| Dividend Yield | ★ 3.87% | N/A |
| EPS Growth | ★ 35.00 | 20.00 |
| EPS | ★ 1.28 | N/A |
| Revenue | N/A | ★ $82,031,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $12.77 |
| P/E Ratio | $35.37 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $39.00 | $5.85 |
| 52 Week High | $50.00 | $24.14 |
Technical Indicators
Market Signals| Indicator | FDBC | ARCT |
|---|---|---|
| Relative Strength Index (RSI) | 52.24 | 31.01 |
| Support Level | $44.42 | $6.08 |
| Resistance Level | $46.36 | $7.88 |
| Average True Range (ATR) | 0.81 | 0.63 |
| MACD | -0.07 | -0.26 |
| Stochastic Oscillator | 58.37 | 0.00 |
Price Performance
Historical ComparisonAbout FDBC Fidelity D & D Bancorp Inc.
Fidelity D & D Bancorp Inc is a bank holding company. Through its wholly-owned state-chartered commercial bank subsidiary, The Fidelity Deposit and Discount Bank (the Bank), it offers a full range of traditional banking services. The Bank has a personal and corporate trust department and also provides alternative financial and insurance products with asset management services. Its primary market areas are Lackawanna, Luzerne and Northampton Counties, Pennsylvania. The company's primary deposit products are demand deposits and interest-bearing time, money market and savings accounts. It offers a full array of loan products to meet the needs of retail and commercial customers. Company includes segments: Commercial and Industrial, Commercial Real Estate, Consumer, Residential Real Estate.
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.